CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-20 | O'Byrne Jason Chief Financial Officer | Grant or award · Option to purchase Common Stock | +147,000 | 147,000 | ||
| 2021-12-20 | MCCLUNG BARBARA G Chief Legal Officer | Grant or award · Option to purchase Common Stock | +147,000 | 147,000 | ||
| 2021-12-20 | Kanner Steven Chief Scientific Officer | Grant or award · Option to purchase Common Stock | +147,000 | 147,000 | ||
| 2021-12-20 | Haurwitz Rachel E. President and CEO | Grant or award · Option to purchase Common Stock | +411,000 | 411,000 | ||
| 2021-12-20 | GUGGENHIME ANDREW Director | Grant or award · Option to purchase Common Stock | +27,500 | 27,500 | ||
| 2021-12-20 | Fischesser Ryan VP of Finance and Controller | Purchase | +1,136 | $2.69 | $3K | 101,695 |
| 2021-12-20 | Fischesser Ryan VP of Finance and Controller | Option exercise · Option to purchase Common Stock | −1,136 | 7,384 | ||
| 2021-12-20 | Fischesser Ryan VP of Finance and Controller | Grant or award · Option to purchase Common Stock | +40,000 | 40,000 | ||
| 2021-12-20 | Braunstein Scott Director | Grant or award · Option to purchase Common Stock | +27,500 | 27,500 | ||
| 2021-12-07 | MCCLUNG BARBARA G Chief Legal Officer | Purchase | +12 | $2.69 | $32 | 342,856 |
| 2021-12-07 | MCCLUNG BARBARA G Chief Legal Officer | Purchase | +6,115 | $2.69 | $16K | 348,971 |
| 2021-12-07 | MCCLUNG BARBARA G Chief Legal Officer | Option exercise · Option to purchase Common Stock | −12 | 77 | ||
| 2021-12-07 | MCCLUNG BARBARA G Chief Legal Officer | Option exercise · Option to purchase Common Stock | −6,115 | 74,836 | ||
| 2021-11-15 | Khan Ruhi Ahmad Chief Business Officer | Grant or award · Option to purchase Common Stock | +225,000 | 225,000 | ||
| 2021-11-11 | Richardson-Heron Dara Director | Grant or award · Option to purchase Common Stock | +44,000 | 44,000 | ||
| 2021-10-20 | MCCLUNG BARBARA G Chief Legal Officer | Purchase | +9,176 | $2.69 | $25K | 342,801 |
| 2021-10-20 | MCCLUNG BARBARA G Chief Legal Officer | Purchase | +43 | $2.69 | $116 | 342,844 |
| 2021-10-20 | MCCLUNG BARBARA G Chief Legal Officer | Option exercise · Option to purchase Common Stock | −9,176 | 80,951 | ||
| 2021-10-20 | MCCLUNG BARBARA G Chief Legal Officer | Option exercise · Option to purchase Common Stock | −43 | 89 | ||
| 2021-10-12 | Kanner Steven Chief Scientific Officer | Purchase | +99,548 | $1.81 | $180K | 199,719 |
Page 8 of 9 · 177 trades